| Antiviral re-treatment of IFN-Ribavirin non-responders for recurrent post-transplantation hepatitis C. | |
| | |
MedLine Citation:
|
PMID: 20438578 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Yedibela S, Demir R, Melling N, Aydin Ü, Schuppan D, Müller V, Hohenberger W, Schönleben F. Antiviral re-treatment of IFN-Ribavirin non-responders for recurrent post-transplantation hepatitis C. Clin Transplant 2011: 25: 131-135. © 2010 John Wiley & Sons A/S. Abstract: Background: The aim of the study was to compare the efficacy and tolerability of pegylated interferon (PEG-IFN) plus ribavirin (RIB) and PEG-IFN monotherapy after unsuccessful initial therapy with interferon-α2b (IFN) plus RIB after recurrent post-transplantation hepatitis C. Methods: Twenty-four patients with either no response (n = 10) or relapse (n = 14) after treatment with IFN plus RIB were prospectively randomized in the two treatment arms: 1) PEG-IFN monotherapy at a dosage of 0.8 μg/kg per week (n = 12) and 2) PEG-IFN (0.8 μg/kg per week) plus RIB (800-1200 mg/d) (n = 12). Results: Twenty-one patients (86%) were treated for at least six months. Three patients are still being treated. At the end of therapy, 18 patients (75%) were HCV RNA negative. Five (45%) patients in PEG-IFN and five (50%) in PEG-IFN plus RIB arms had sustained virological response. Two patients (10%) died from recurrent hepatocellular carcinoma. The histologic activity indices significantly improved in both treatment arms. In the PEG-IFN arm, one patient experienced an acute rejection and discontinued therapy. Conclusions: Both treatment arms showed to be effective, well tolerated and lead to an improvement in histologic outcome. Because of lower rates in side effects and equal outcome, PEG-IFN monotherapy is an adequate option for antiviral re-treatment. |
| | |
Authors:
|
Süleyman Yedibela; Resit Demir; Nathaniel Melling; Unal Aydin; Detlef Schuppan; Volker Müller; Werner Hohenberger; Frank Schönleben |
Related Documents
:
|
8845268 - Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2b treatment i... 8418228 - A randomized clinical trial comparing melphalan/prednisone with or without interferon a... 3679588 - Interferon treatment of human genital papillomavirus infection: importance of viral type. 15880608 - Long-term follow-up of peginterferon and lamivudine combination treatment in hbeag-posi... 19795328 - The role of meteorological conditions on the development of spontaneous pneumothorax. 17767478 - Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angi... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical transplantation Volume: 25 ISSN: 1399-0012 ISO Abbreviation: Clin Transplant Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-02-08 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8710240 Medline TA: Clin Transplant Country: Denmark |
Other Details:
|
Languages: eng Pagination: 131-5 Citation Subset: IM |
Copyright Information:
|
© 2010 John Wiley & Sons A/S. |
Affiliation:
|
Department of General Surgery, University of Erlangen-Nuremberg, Krankenhausstr, Erlangen, Germany Department of General Surgery, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey Beth Israel Deaconess Medical Center, Boston, MA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipient...
Next Document: Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it s...